{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:56:03Z","timestamp":1767826563354,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.102","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T11:33:10Z","timestamp":1510140790000},"page":"7309-7311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adverse effects of single-component measles vaccine in school children"],"prefix":"10.1016","volume":"35","author":[{"given":"Selam","family":"Tosun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ilg\u0131n","family":"Olut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermin","family":"Tansug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.102_b0005","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.10.102_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/381592","article-title":"The theory of measles elimination: implications for the design of elimination strategies","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.102_b0015","series-title":"WHO immunological basis for immunization series: measles","author":"Moss","year":"2009"},{"key":"10.1016\/j.vaccine.2017.10.102_b0020","unstructured":"Supplementary information on vaccine safety, Part 2; Background rates of adverse events following immunization. Geneva: WHO; 2000."},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.102_b0025","first-page":"153","article-title":"Centers for disease control and prevention (CDC). Measles outbreak\u2014California, December 2014\u2013February 2015","volume":"64","author":"Zipprich","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"10.1016\/j.vaccine.2017.10.102_b0030","doi-asserted-by":"crossref","first-page":"20580","DOI":"10.2807\/1560-7917.ES2013.18.36.20580","article-title":"Large ongoing measles outbreak in a religious community in the Netherlands since May 2013","volume":"18","author":"Knol","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2017.10.102_b0035","doi-asserted-by":"crossref","unstructured":"Vatev NT, Stoycheva MV, Petrov AIBraz. Reemergence of measles in Bulgaria: a large outbreak in Plovdiv, 2010. J Infect Dis 2011;15(6):613\u20136 [Nov\u2013Dec].","DOI":"10.1590\/S1413-86702011000600021"},{"issue":"Supp. 5","key":"10.1016\/j.vaccine.2017.10.102_b0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1469-0691.12584","article-title":"The state of measles and rubella in the WHO European Region, 2013","volume":"20","author":"Muscat","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2017.10.102_b0045","unstructured":"WHO Measles fact sheet; 2017. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs286\/en>."},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2017.10.102_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-0691.2012.03982.x","article-title":"Measles still spreads in Europe: who is responsible for the failure to vaccinate?","volume":"18","author":"Carrillo-Santisteve","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"34","key":"10.1016\/j.vaccine.2017.10.102_b0055","first-page":"4180","article-title":"Strategies for addressing vaccine hesitancy - a systematic review","volume":"33","author":"Jarrett","year":"2015","journal-title":"SAGE Working Group Vaccine Hesitancy Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2017.10.102_b0060","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1016\/j.vaccine.2012.09.053","article-title":"Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak","volume":"30","author":"Abedi","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.102_b0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamapediatrics.2016.1787","article-title":"Measles and measles vaccination: a review","volume":"170","author":"Bester","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.102_b0070","first-page":"91","article-title":"Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran","volume":"14","author":"Esteghamati","year":"2011","journal-title":"Arch Iran Med"},{"issue":"48","key":"10.1016\/j.vaccine.2017.10.102_b0075","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1016\/j.vaccine.2012.08.057","article-title":"Measles, mumps, and rubella virus vaccine (M-M-R\u2122II): a review of 32 years of clinical and postmarketing experience","volume":"30","author":"Lievano","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T17:11:11Z","timestamp":1570295471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17315311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":15,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17315311"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse effects of single-component measles vaccine in school children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}